Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1, ribosome biogenesis factor pseudogene 8 (BMS1P8) is classified as an unprocessed pseudogene mapped to human chromosome 10, with the Ensembl gene ID ENSG00000260518. Pseudogenes such as BMS1P8 originate from duplication or retrotransposition events and generally do not encode functional proteins or serve as classical therapeutic targets. There is no evidence suggesting that BMS1P8 is involved in molecular pathways, disease mechanisms, or therapeutic modulation. While pseudogenes can occasionally exert regulatory effects, such as by acting as competing endogenous RNAs, there is no specific research implicating BMS1P8 in such functions. Due to its lack of protein-coding capacity and direct biological relevance, BMS1P8 is not considered a therapeutic or diagnostic target and is generally excluded from catalogs of actionable drug targets. If your interest is in the related protein-coding gene, refer to BMS1 (BMS1 Ribosome Biogenesis Factor), which does play a role in ribosomal subunit assembly and cellular RNA metabolism, but this does not pertain to BMS1P8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1, ribosome biogenesis factor pseudogene 8 (BMS1P8).